David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.09% |
| 2 | Technology | 17.04% |
| 3 | Healthcare | 13.44% |
| 4 | Consumer Discretionary | 13.38% |
| 5 | Financials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
2026
CALL
Gilead Sciences
GILD
$185B
| $2.29M | ﹤0.01% |
35,200
-53,700
| -60% | -$3.57M |
|
2027
US Bancorp
USB
$97.2B
| $2.28M | ﹤0.01% |
+47,301
| New | +$2.37M |
|
|
MCHB
2028
Mechanics Bancorp
MCHB
$3.55B
| $2.28M | ﹤0.01% |
86,400
-90,388
| -51% | -$2.35M |
|
2029
Western Alliance Bancorporation
WAL
$8.57B
| $2.28M | ﹤0.01% |
55,454
+37,154
| +203% | +$1.64M |
|
2030
Mercer International
MERC
$33.1M
| $2.27M | ﹤0.01% |
168,141
-91,266
| -35% | -$1.25M |
|
2031
Vitamin Cottage Natural Grocers
NGVC
$627M
| $2.27M | ﹤0.01% |
189,996
-103,065
| -35% | -$1.46M |
|
|
GBT
2032
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.27M | ﹤0.01% |
42,823
+17,662
| +70% | +$868K |
|
2033
CALL
Under Armour
UAA
$2.22B
| $2.27M | ﹤0.01% |
107,200
-185,600
| -63% | -$3.89M |
|
2034
PUT
Albemarle
ALB
$16B
| $2.26M | ﹤0.01% |
27,600
-12,300
| -31% | -$1.01M |
|
|
TBHC
2035
DELISTED
The Brand House Collective
TBHC
| $2.26M | ﹤0.01% |
321,420
-103
| -0% | -$1.01K |
|
2036
PUT
Cisco
CSCO
$441B
| $2.26M | ﹤0.01% |
41,800
-962,000
| -96% | -$46.7M |
|
2037
Gogo Inc
GOGO
$366M
| $2.25M | ﹤0.01% |
+501,257
| New | +$2.09M |
|
2038
PUT
Parker-Hannifin
PH
$128B
| $2.25M | ﹤0.01% |
13,100
-23,200
| -64% | -$3.85M |
|
|
HA
2039
PUT
DELISTED
Hawaiian Holdings, Inc.
HA
| $2.24M | ﹤0.01% |
85,500
+17,700
| +26% | +$514K |
|
2040
Oaktree Specialty Lending
OCSL
$1.15B
| $2.24M | ﹤0.01% |
144,278
-2,743
| -2% | -$40.9K |
|
2041
CALL
Genuine Parts
GPC
$19.1B
| $2.24M | ﹤0.01% |
20,000
-4,500
| -18% | -$466K |
|
2042
CALL
Howard Hughes
HHH
$3.95B
| $2.23M | ﹤0.01% |
21,295
-5,245
| -20% | -$543K |
|
2043
Donaldson
DCI
$10.7B
| $2.23M | ﹤0.01% |
44,518
-72,229
| -62% | -$3.49M |
|
2044
UBS Group
UBS
$167B
| $2.23M | ﹤0.01% |
183,990
-273,126
| -60% | -$3.46M |
|
2045
PUT
Aptiv
APTV
$9.66B
| $2.23M | ﹤0.01% |
28,000
| – | – |
|
2046
Franklin Electric
FELE
$4.51B
| $2.23M | ﹤0.01% |
43,555
+2,175
| +5% | +$107K |
|
|
CXO
2047
CALL
DELISTED
CONCHO RESOURCES INC.
CXO
| $2.22M | ﹤0.01% |
20,000
+15,000
| +300% | +$1.7M |
|
2048
Columbus McKinnon
CMCO
$521M
| $2.22M | ﹤0.01% |
64,540
-12,203
| -16% | -$425K |
|
2049
eHealth
EHTH
$38.4M
| $2.21M | ﹤0.01% |
35,479
-67,244
| -65% | -$3.71M |
|
|
OTIC
2050
DELISTED
Otonomy, Inc.
OTIC
| $2.21M | ﹤0.01% |
840,868
-18,970
| -2% | -$42.7K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $2.66B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.